Comparison of Diane 35 plus Finasteride combination with Diane 35 plus Spironolactone in the treatment of hirsutism with six months follow-up after stopping the drug.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2010/091/000593

Enrollment

120

Registered

2010-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Diane 35 plus Finasteride: Diane 35 from Day 5 to Day 25 of MC and Finasteride 5 mg per day for 12 months Control Intervention1: Diane 35 plus Spironolactone: Diane 35 from Day 5 to Day

Eligibility

Inclusion criteria

Inclusion criteria: -Women with hirsutism score more than 8 - Age between 18 -40years

Exclusion criteria

Exclusion criteria: - postmenoopausal women - pregnant women - CAH - already on some medication

Design outcomes

Secondary

Measure	Time frame
Reduction in acne scoreTimepoint: 3,6,9,12 and 18 months	—

Primary

Measure	Time frame
Reduction in Hisutism scoreTimepoint: 3,6,9, 12 and 18 months	—

Countries

India

Contacts

Public ContactDr Garima Kachhawa

kriplanialka@gmail.com26594933

Outcome results